We go beyond funding. We integrate our expertise in global markets, luxury consumer behavior, and sustainable technology to actively guide our partners from growth to maturity.
In the heart of the Riviera, at the crossroads of European innovation, FG MONACO operates with a distinct philosophy. We believe true value is created not just through capital, but through cultivated partnerships. Our approach is characterized by discretion, a long-term perspective, and an unwavering commitment to the success of our portfolio companies.
FG MONACO was founded on the principle that the most significant value is created through deep, strategic partnerships, not passive capital. We combine the disciplined approach of a global institution with the agility and network of a specialized private firm.
FG MONACO is a private investment firm based in Monaco. We provide strategic capital and operational expertise to visionary entrepreneurs building leading technology and consumer companies across Europe.
We are active, hands-on investors, not silent financiers.
Deeply embedded in Monaco and Europe, with a reach that is truly international.
We align our success with yours, focusing on sustainable value creation over quarterly returns.
Our team brings together decades of experience in investment banking, corporate strategy, and operational leadership. From our vantage point in Monaco, we offer a unique gateway to European markets and a global perspective for our portfolio companies.
We target innovative companies that demonstrate a clear competitive advantage, scalable business models, and exceptional leadership teams. Our focus is concentrated on high-growth potential within specific, forward-looking sectors.
Investing in the technologies and businesses shaping a more sustainable future, from clean energy to circular economy solutions.
Partnering with emerging and established brands that define elegance, craftsmanship, and exclusivity in the modern marketplace.
Supporting groundbreaking advancements in healthcare technology, diagnostics, and biopharmaceuticals that improve patient outcomes.
We seek to partner with exceptional founders and management teams who are building durable businesses with sustainable competitive advantages. Our capital is deployed behind a rigorous set of criteria.
